[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Humana Inc (HUM)

Humana Inc (HUM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Humana Has Beat Estimates Three Times Running While Its Stock Refuses to Follow

Humana Inc. (HUM) reports second-quarter earnings before the market opens on July 29, 2026, with analysts expecting $6.22 per share — a sharp decline from the prior year's $6.27. The central question: can the Medicare Advantage giant stabilize profitability after a volatile year that saw a $3.96 loss in Q4 2025, or will mounting pressures in its core business drive another disappointing quarter?

Humana Inc. is one of the nation's largest health insurance providers, specializing in Medicare Advantage plans, prescription drug coverage, and other healthcare services for seniors and government-sponsored beneficiaries. The company's performance is closely tied to medical cost trends, government reimbursement rates, and enrollment dynamics...

Fundamentals

See More
  • Market Capitalization, $K 46,669,296
  • Shares Outstanding, K 120,062
  • Annual Sales, $ 129,664 M
  • Annual Income, $ 1,188 M
  • EBIT $ 3,122 M
  • EBITDA $ 3,946 M
  • 60-Month Beta 0.71
  • Price/Sales 0.35
  • Price/Cash Flow 15.84
  • Price/Book 2.45

Options Overview Details

View History
  • Implied Volatility 44.14% (-16.05%)
  • Historical Volatility 37.54%
  • IV Percentile 38%
  • IV Rank 33.01%
  • IV High 78.24% on 03/30/26
  • IV Low 27.33% on 08/20/25
  • Expected Move (DTE 1) 12.50 (3.42%)
  • Put/Call Vol Ratio 1.37
  • Today's Volume 8,352
  • Volume Avg (30-Day) 4,273
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 110,751
  • Open Int (30-Day) 105,405
  • Expected Range 352.92 to 377.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.22
  • Number of Estimates 8
  • High Estimate $1.27
  • Low Estimate $-2.14
  • Prior Year $3.24
  • Growth Rate Est. (year over year) -106.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
355.81 +2.70%
on 07/29/26
428.88 -14.80%
on 07/16/26
-23.49 (-6.04%)
since 06/29/26
3-Month
231.12 +58.10%
on 05/01/26
428.88 -14.80%
on 07/16/26
+122.29 (+50.30%)
since 04/29/26
52-Week
163.11 +124.03%
on 03/20/26
428.88 -14.80%
on 07/16/26
+132.79 (+57.08%)
since 07/29/25

Most Recent Stories

More News
Humana (HUM) Stock Trades Down, Here Is Why

Humana (HUM) Stock Trades Down, Here Is Why

HUM : 365.41 (-5.99%)
Humana (NYSE:HUM) Exceeds Q2 CY2026 Expectations

Humana (NYSE:HUM) Exceeds Q2 CY2026 Expectations

HUM : 365.41 (-5.99%)
Humana Elects Paul Smith and Frederick Crawford to Board of Directors

Smith is the Chief Commercial Officer at Anthropic PBC and brings 30+ years scaling go-to-market strategies at the world's leading enterprise technology companies ...

HUM : 365.41 (-5.99%)
Humana: Q2 Earnings Snapshot

Humana: Q2 Earnings Snapshot

HUM : 365.41 (-5.99%)
Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

Reports 2Q26 earnings per share (EPS) of $5.73 on a GAAP basis, Adjusted EPS of $7.61; reports year to date (YTD) 2026 EPS of $15.55 on a GAAP basis, $17.91 on an Adjusted basis 2Q26...

HUM : 365.41 (-5.99%)
Humana Has Beat Estimates Three Times Running While Its Stock Refuses to Follow

Barchart Research What to Expect from HUM Earnings HUM Generated July 28, 2026 Current Price $388.71 EPS Estimate $$6.22 Consensus Rating Moderate Buy Average Move 5.76% Humana Has Beat Estimates Three...

HUM : 365.41 (-5.99%)
New Humana Healthcare Research Study Finds Favorable Selection in Medicare Advantage is Substantially Lower Than MedPAC Estimates

Published in Health Affairs Scholar, the study finds that a single methodological refinement reduces favorable selection estimates by 42%-65%, suggesting a smaller impact on MA payments than previous analyses...

HUM : 365.41 (-5.99%)
Humana (HUM) Reports Q2: Everything You Need To Know Ahead Of Earnings

Humana (HUM) Reports Q2: Everything You Need To Know Ahead Of Earnings

HUM : 365.41 (-5.99%)
Humana Inc. (NYSE: HUM) Investor Reminder: Schubert Jonckheer Investigating Possible False Statements Following 22% Stock Drop

SAN FRANCISCO , July 27, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP reminds Humana Inc. (NYSE: HUM) investors that the firm is investigating potential legal claims arising from alleged...

HUM : 365.41 (-5.99%)
Kaskela Law Firm Announces Investigation of Humana Inc. (HUM) and Encourages Long-Term HUM Shareholders to Contact the Firm

Investor litigation firm Kaskela Law announces that it is investigating Humana Inc. (NYSE: HUM) (“Humana”) on behalf of the company’s long-term investors. ...

HUM : 365.41 (-5.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Humana Inc. is a health care plan provider in the United States. The company provides health insurance benefits under Health Maintenance Organization, Private Fee-For-Service and Preferred Provider Organization plans. The company also provides other benefits with specialty products including dental,...

See More

Key Turning Points

3rd Resistance Point 428.02
2nd Resistance Point 411.66
1st Resistance Point 388.54
Last Price 365.41
1st Support Level 349.05
2nd Support Level 332.69
3rd Support Level 309.56

See More

52-Week High 428.88
Last Price 365.41
Fibonacci 61.8% 327.36
Fibonacci 50% 296.00
Fibonacci 38.2% 264.63
52-Week Low 163.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.